Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.85%42 Return-on-Tangible-Asset is 1.68% as of Mar. 2026, which is 77% below its 10-year median of 7.33. GuruFocus rates ROCO:1295 with a GF Score™ of 42/100. The stock has 9 warning signs investors should review. Among 1,414 Biotechnology companies, Synbio Tech ranks better than 87.06% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Synbio Tech's annualizedNet Income for the quarter that ended in Mar. 2026 was NT$53 Mil. Synbio Tech's average total tangible assets for the quarter that ended in Mar. 2026 was NT$3,169 Mil. Therefore, Synbio Tech's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 1.68%.
The historical rank and industry rank for Synbio Tech's Return-on-Tangible-Asset or its related term are showing as below:
ROCO:1295'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.21 Med: 7.33 Max: 11.1
Current: 5.21
During the past 6 years, Synbio Tech's highest Return-on-Tangible-Asset was 11.10%. The lowest was 5.21%. And the median was 7.33%.
ROCO:1295's Return-on-Tangible-Asset is ranked better than 87.06% of 1414
companies
in the Biotechnology industry
Industry Median: -36.16
vs ROCO:1295: 5.21
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Synbio Tech Return-on-Tangible-Asset Related Terms
Synbio Tech Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Synbio Tech's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, RVMD: Return-on-Tangible-Asset Comparison
For the Biotechnology subindustry, Synbio Tech's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech Return-on-Tangible-Asset vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Synbio Tech's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 1.68% mean?
Synbio Tech (ROCO:1295) has a Return-on-Tangible-Asset of 1.68% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Synbio Tech and its competitors. This is 77% below median its historical median of 7.33. Over the past decade, Synbio Tech's Return-on-Tangible-Asset has ranged from 5.21 to 11.10. According to the industry distribution chart, Synbio Tech ranks #183 out of 1414 companies in the Biotechnology industry, placing it in the top 12.9%.
Is Synbio Tech's Return-on-Tangible-Asset too high?
Synbio Tech's current Return-on-Tangible-Asset of 1.68% is 77% below median its 10-year median of 7.33. Over the past 10 years, this metric has ranged from a low of 5.21 to a high of 11.10. Based on the distribution chart, Synbio Tech ranks #183 out of 1414 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Synbio Tech has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Return-on-Tangible-Asset compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #183 out of 1414 companies for Return-on-Tangible-Asset. This places Synbio Tech in the top 13% of its industry — outperforming the majority of peers. Historically, Synbio Tech's own Return-on-Tangible-Asset has ranged from 5.21 to 11.10 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Biotechnology company?
A good Return-on-Tangible-Asset depends on the Biotechnology industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Synbio Tech and its competitors. Synbio Tech's current Return-on-Tangible-Asset is 1.68%, which is 77% below median its own 10-year median of 7.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Return-on-Tangible-Asset of 1.68%. The current Return-on-Tangible-Asset is 1.68%, which is 77% below median its 10-year median of 7.33. Synbio Tech's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Return-on-Tangible-Asset is 1.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
42GF Score
Get the complete analysis for ROCO:1295
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
